Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NAEFX | 66.76 | 0.89 | +1.35% |
| New Alternatives Investor | |||
| TESGX | 8.38 | 0.04 | +0.48% |
| Templeton Global Smaller Comp C | |||
| NBRCX | 23.92 | 0.08 | +0.34% |
| Neuberger Berman M/C Intrinsic Val C | |||
| FFNTX | 13.04 | 0.02 | +0.15% |
| Fidelity Advisor Asset Manager 40% M | |||
| WFPCX | 41.43 | 0.02 | +0.05% |
| Allspring Special Mid Cap Value C | |||
A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.
| Ticker / NAME | Correlation To HLUBF | 1D Price Change % | ||
|---|---|---|---|---|
| HLUBF | 100% | N/A | ||
| HLBBF - HLUBF | 18% Poorly correlated | N/A | ||
| HLNCF - HLUBF | 7% Poorly correlated | +9.41% | ||
| ESAIY - HLUBF | 5% Poorly correlated | +0.73% | ||
| AKAN - HLUBF | 2% Poorly correlated | -3.60% | ||
| HLN - HLUBF | 1% Poorly correlated | +1.61% | ||
More | ||||
| Ticker / NAME | Correlation To HLUBF | 1D Price Change % |
|---|---|---|
| HLUBF | 100% | N/A |
| Pharmaceuticals category (303 stocks) | 13% Poorly correlated | +0.03% |
| Pharmaceuticals: Other category (210 stocks) | 9% Poorly correlated | +0.40% |